Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
about
Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET ImagingRepopulation of tumor cells during fractionated radiotherapy and detection methods (Review).PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceEvaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation.Molecular imaging in tracking tumor stem-like cellsDevelopment of copper based drugs, radiopharmaceuticals and medical materials.Monitoring cancer stem cells: insights into clinical oncology.Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.Biological imaging in clinical oncology: radiation therapy based on functional imaging.64Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts.Multiple Administrations of 64Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts.Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts.
P2860
Q26784016-6ECF3B38-7A4B-4AF3-9C93-4E6806D055D4Q33727528-7F39846D-890C-4CDC-A7B8-E56979110ED3Q33818999-13213A52-4A91-4FDB-B35E-35397F13BA36Q34696310-6FEC5593-7BD0-412A-BA53-E57674B7D637Q35108628-785EB919-0179-4C5C-B9AC-EF04B5D733DDQ35909465-36C3F317-44DE-46DC-9FF9-21593DA874D9Q36394415-9AFCB32C-F937-4DAB-85E3-202C462C4387Q36585140-83BC1ECF-8ADC-420C-A9D2-E6FAA0EA978AQ37506093-05D5F1A5-0C3F-45C0-A770-3876C910AC62Q37853427-7F48008E-60E8-4B44-B812-5DD48115BDE3Q38887987-FEF9C9F9-898E-4960-B29F-0EE9E4B58563Q47115808-E644F0CE-C5E6-4240-AC90-EEAB73DCCFF7Q47124032-B3B58B26-EB48-4BF9-8850-92DB2B29FB2AQ55508871-279AFE05-4029-4A21-B13F-A947ECAA1633
P2860
Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Internal radiotherapy with cop ...... lity of mouse colon carcinoma.
@en
Internal radiotherapy with copper-64-diacetyl-bis
@nl
type
label
Internal radiotherapy with cop ...... lity of mouse colon carcinoma.
@en
Internal radiotherapy with copper-64-diacetyl-bis
@nl
prefLabel
Internal radiotherapy with cop ...... lity of mouse colon carcinoma.
@en
Internal radiotherapy with copper-64-diacetyl-bis
@nl
P2093
P1476
Internal radiotherapy with cop ...... lity of mouse colon carcinoma.
@en
P2093
Hiroshi Yoshii
Michael J Welch
Ryo Watanabe
Takako Furukawa
Tatsuya Asai
Tetsuya Mori
Yasuhisa Fujibayashi
Yasushi Kiyono
Yukie Yoshii
P304
P356
10.1016/J.NUCMEDBIO.2010.08.009
P577
2010-10-27T00:00:00Z